Francesco Galimi

Direttore Tecnico/Scientifico/R&S presso ADICET BIO, INC.

Patrimonio netto: 184 260 $ in data 30/04/2024

56 anni

Health Technology

Consumer Services

Posizioni attive di Francesco Galimi

Società	Posizione	Inizio	Fine
ADICET BIO, INC.	Direttore Tecnico/Scientifico/R&S	01/09/2019	-
Adicet Therapeutics, Inc. Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA.	Direttore Tecnico/Scientifico/R&S	01/09/2019	-

Società	Posizione	Inizio	Fine
AMGEN INC.	Corporate Officer/Principal	01/01/2015	01/01/2019
Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	Corporate Officer/Principal	01/01/2014	01/01/2015
ADICET BIO, INC.	Direttore Tecnico/Scientifico/R&S	15/09/2020	-

University of Turin

Doctorate Degree

Distribuzione geografica

Stati Uniti	6
Italia	2

Posizioni

Chief Tech/Sci/R&D Officer	3
Corporate Officer/Principal	2
Doctorate Degree	1

Settori

Health Technology	6
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	2
ADICET BIO, INC.	Health Technology
AMGEN INC.	Health Technology

Aziende private	3
resTORbio, Inc. resTORbio, Inc. BiotechnologyHealth Technology resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, MA.	Health Technology
Adicet Therapeutics, Inc. Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA.	Health Technology
Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	Health Technology